Looking at harm minimisation

Methadone, buprenorphine, drug testing, naloxone and more: we discuss the latest views and opinions with a panel of experts Why is the naloxone program not seeing wider take-up? Should pharmacists be able to inject buprenorphine? Should pharmacies be able to offer drug testing? Are pharmacies offering stigma-free methadone provision? Regular AJP contributor and leading addiction

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Week in review
Next Hospital concerns met